TCI Wealth Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,117
Closed -$9.18K 1432
2023
Q1
$9.18K Buy
1,117
+1,002
+871% +$11.1K ﹤0.01% 1145
2022
Q4
$1.28K Sell
115
-977
-89% -$11.4K ﹤0.01% 2073
2022
Q3
$13K Buy
1,092
+118
+12% +$1.79K ﹤0.01% 870
2022
Q2
$15K Buy
974
+294
+43% +$5.29K ﹤0.01% 769
2022
Q1
$14K Sell
680
-281
-29% -$6.05K ﹤0.01% 888
2021
Q4
$23K Buy
961
+152
+19% +$3.26K ﹤0.01% 650
2021
Q3
$16K Buy
809
+120
+17% +$2.46K ﹤0.01% 789
2021
Q2
$14K Buy
689
+83
+14% +$1.77K ﹤0.01% 751
2021
Q1
$13K Buy
606
+268
+79% +$5.76K 0.01% 718
2020
Q4
$7K Buy
338
+27
+9% +$526 ﹤0.01% 756
2020
Q3
$5K Buy
311
+201
+183% +$3.74K ﹤0.01% 777
2020
Q2
$2K Buy
110
+1
+0.9% +$18 ﹤0.01% 1082
2020
Q1
$2K Buy
109
+53
+95% +$1.11K ﹤0.01% 1045
2019
Q4
$1K Sell
56
-265
-83% -$5.37K ﹤0.01% 1383
2019
Q3
$6K Buy
321
+266
+484% +$4.89K ﹤0.01% 763
2019
Q2
$1K Buy
55
+1
+2% +$18 ﹤0.01% 1252
2019
Q1
$1K Buy
+54
New +$963 ﹤0.01% 1262

Other funds holding MPT

TCI Wealth Advisors's MPT Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Medical Properties Trust (MPT) in Q2 2023, closing a stake of 1,117 shares — an estimated $9.18K sold.

TCI Wealth Advisors first reported a position in MPT in Q1 2019 and held it in 17 quarters. The position peaked at $23K in Q4 2021. 596 funds tracked by Wall St. Rank hold MPT as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Medical Properties Trust position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 1,117 Medical Properties Trust shares in Q2 2023, an estimated $9.18K.
  • TCI Wealth Advisors first reported a position in Medical Properties Trust in Q1 2019 and held it in 17 quarters.
  • TCI Wealth Advisors's Medical Properties Trust position peaked at $23K in Q4 2021.
  • 596 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.